For which medication is the frequency of dosing indicated as "daily"?

The correct answer is based on the dosing regimen for the medication Tiotropium/Olodaterol. Tiotropium is a long-acting muscarinic antagonist (LAMA), and Olodaterol is a long-acting beta-agonist (LABA). This combination is indicated for once-daily use, making it convenient for patients who need chronic management of respiratory conditions such as chronic obstructive pulmonary disease (COPD).

Once-daily dosing helps improve patient adherence, as simpler regimens are easier for patients to maintain. In contrast, the other medications listed are typically used with more frequent dosing schedules—Symbicort HFA is usually administered twice daily, and Brovana is typically given twice a day, while Arcapta Neohaler is dosed once daily but is a single agent, not in combination. Thus, the dosing frequency of Tiotropium/Olodaterol aligns with the requirement of being taken daily, supporting its role in managing respiratory conditions effectively.